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presentation to CD8+ T cells. Specific deletion of WASp in
DCs using CD11c-Cre bred to a loxP-flanked WASp allele
led to marked expansion of CD8+ T cells at the expense of
CD4+ T cells. WASp-deficient DCs induced increased
cross-presentation to CD8+ T cells by activating Rac2 that
maintains a near neutral pH of phagosomes. To address if
WASp directly reduces cross-presentation in DCs, we
placed back WASp in bone marrow-derived DCs using
Amaxa transfection. WASp-deficient DCs transfected with
wild-type WASp restored acidification capacity resulting
in decreased proliferation of CD8+ T cells. To identify if
actin polymerization by WASp is needed to dampen cross-
presentation, we expressed WASp lacking the actin-
binding VCA domain in WASp-deficient DCs. The
WASpΔVCA increased acidification and reduced prolifer-
ation of CD8+ T cells, suggesting that the VCA domain of
WASp is dispensable for reducing cross-presentation.
Together, our data reveals an intricate balance between
activation of WASp and Rac2 signaling pathways in DCs.
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Introduction: Fibrinogen C domain-containing 1
(FIBCD1) is a homotetrameric type II transmembrane
protein, expressed at epithelial surfaces. FIBCD1 has a wide
ligand spectrum, including chitin found in various
pathogens such as helminths and fungi. Current under-
standing points towards a role as a pattern recognition
receptor in the innate immune response.
Aim: In the present study, we investigate the localization
of FIBCD1 in 49 different healthy human tissues by
immunohistochemistry. Further, we investigate the in vitro
effects of excretory-secretory (ES) antigens from pig
whipworm (Trichuris suis) on FIBCD1-transfected colon
epithelial cells, and identify protein fractions in the ES-
antigen that binds to FIBCD1.
Results: Immunohistochemical staining shows that FIBCD1
is present at mucosal surfaces throughout the human body,
with high intensity in the airways and gastrointestinal and
urogenital tract. Transfection of the human colon epithelial
cell line HCT116 with FIBCD1 did not result in any major
genotypic differences upon stimulation with ES antigens, as
determined by quantitative PCR of various pro- and anti-
inflammatory genes. FIBCD1 recognizes and binds to
whipworm eggshell and ES antigens. Analysis of the T. suis
ES-antigen by size chromatography reveals predominant sizes
of proteins ranging from 10 kDa to 200 kDa.
Conclusion: FIBCD1 is present at mucosal surfaces
throughout the human body, which may underline its
function as a pattern recognition receptor in the innate
immune system. FIBCD1 binds to ES antigens. Stimula-
tion with ES antigens does not appear to be influenced by
FIBCD1 transfection in vitro. FIBCD1 may play a role in
whipworm infections in vivo.
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Gastrointestinal toxicity is a major dose-limiting adverse
effect of chemotherapeutic treatment. The intestinal barrier
and the adaptive immune system are compromised during
treatment. Deleted in Malignant Brain Tumours 1
(DMBT1) is a secreted scavenger protein with effects on
innate immunity and epithelial differentiation. We inves-
tigated the effect of Dmbt1 deletion on intestinal toxicity
and inflammation after chemotherapeutic treatment inmice.
C57BL/6 mice deficient in DMBT1 (KO) and wild-type
(WT) littermates were treated with intraperitoneal injec-
tions of doxorubicin and terminated on day 3 (D3) or 7
(D7) after treatment. Intestinal inflammation and gas-
trointestinal toxicity was investigated through daily
weighing, serum citrulline levels, histological evaluation
and quantitative real-time PCR analysis of Dmbt1, Tnf,
Il1b and Il6 gene expression.
Doxorubicin treatment induced wasting and gastrointesti-
nal inflammation. Citrulline levels were lower in doxoru-
bicin treated mice D3 compared to saline controls
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